Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials (Q6625555)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials |
scientific article; zbMATH DE number 7932916
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials |
scientific article; zbMATH DE number 7932916 |
Statements
Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trials (English)
0 references
28 October 2024
0 references
neoadjuvant
0 references
oncology
0 references
pathological complete response
0 references
power
0 references
sample size
0 references
survival
0 references
